Name: Amylyx Pharmaceuticals, Inc. (AMLX) Balance Sheet
Creator: FinSpry

Amylyx Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Amylyx Pharmaceuticals, Inc. (AMLX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	77.39	170.20	62.53	50.19	12.88
Short-Term Investments	99.11	201.16	284.42	45.93	0.00
Cash & Short-Term Investments	176.50	371.36	346.95	96.12	12.88
Accounts Receivable	0.55	40.55	15.31	0.00	0.00
Inventory	0.00	38.32	9.77	0.00	0.00
Other Current Assets	12.38	14.43	10.11	5.39	0.76
Total Current Assets	189.43	464.67	382.13	104.95	13.64
Non-Current Assets
Property, Plant & Equipment (Net)	2.73	6.41	8.14	0.47	0.15
Other Non-Current Assets	1.47	46.38	1.19	0.19	0.31
Total Non-Current Assets	4.20	52.79	9.32	0.66	0.00
Total Assets	193.63	517.45	391.45	105.61	14.10
Current Liabilities
Accounts Payable	2.94	22.06	6.26	4.37	3.61
Short-Term Debt	3.04	0.00	0.00	0.00	0.00
Accrued Liabilities	23.95	57.72	23.08	13.02	3.71
Other Current Liabilities	22.43	0.00	4.60	0.00	0.00
Total Current Liabilities	28.41	82.04	46.61	17.40	7.33
Non-Current Liabilities
Long-Term Debt	0.46	1.98	4.24	0.00	1.43
Other Non-Current Liabilities	0.00	0.00	0.00	0.04	0.02
Total Non-Current Liabilities	0.46	1.98	4.24	239.39	0.00
Total Liabilities	28.87	84.02	50.85	17.43	8.77
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.00	0.00
Retained Earnings	-606.69	-304.95	-354.22	-155.85	-67.91
Accumulated Other Comprehensive Income	-0.09	0.20	-0.09	0.01	0.00
Additional Paid-in Capital	771.54	738.18	694.91	4.67	0.00
Shares Outstanding	68.63	67.71	66.51	55.22	0.00
Total Stockholders' Equity	164.77	433.43	340.61	88.18	5.34
Total Liabilities & Equity	193.63	517.45	391.45	105.61	0.00